| Target | ACAA2 |
|---|
| Product Type | Antibody |
|---|
| Application | IF/ICC, IHC (P), WB |
|---|
| Clonality | Polyclonal |
|---|
| Conjugate | unconjugated |
|---|
| Isotype | IgG |
|---|
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-250 of human ACAA2 (NP_006102.2). |
|---|
| Host Species | Rabbit |
|---|
| Species Reactivity | Human, Mouse, Rat |
|---|
| Formulation | PBS with 0.05% Proclin300,50% glycerol |
|---|
| Research Area | Cancer, Epigenetics, Metabolism |
|---|
| Description/Background | The encoded protein catalyzes the last step of the mitochondrial fatty acid beta-oxidation spiral. Unlike most mitochondrial matrix proteins, it contains a non-cleavable amino-terminal targeting signal. |
|---|
| Storage Temperature | Store at -20℃ |
|---|
| Protocols | IF/ICC, IHC (P), WB |
|---|
| Molecular Weight | 42kDa |
|---|
| Purification | Affinity purification |
|---|
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
|---|
